Clinical Trial Update: Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease [Phase 3]

View source ↗

Summary

Phase 3 randomized, placebo-controlled study of tinlarebant in adolescents with Stargardt disease has completed, with safety and efficacy data to be analyzed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stargardt Disease

Drugs mentioned

• Tinlarebant

Snippet

Sponsor: Belite Bio, Inc | Conditions: Stargardt Disease 1 | Phase 3 | Status: COMPLETED